 The proposed study represents an informed estimate based on current knowledge of SBRT doses and those administered in currently approved image-guided protocols brain, base of skull, cervico-thoracic spine, pancreas and liver. This study will refine the current understanding of single fraction radiation tolerance for normal tissues, thereby making it possible to treat future patients more safely and aggressively. 